Article
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin.
Journal of experimental & clinical cancer research : CR - 27 Nov 2023
Castaldo Vittorio, Minopoli Michele, Di Modugno Francesca, Sacconi Andrea, Liguoro Domenico, Frigerio Rachele, Ortolano Arianna, Di Martile Marta, Gesualdi Luisa, Madonna Gabriele, Capone Mariaelena, Cirombella Roberto, Catizone Angiolina, Del Bufalo Donatella, Vecchione Andrea, Carriero Maria Vincenza, Ascierto Paolo Antonio, Mancini Rita, Fattore Luigi, Ciliberto Gennaro
Abstract excerpt
BACKGROUND: BRAF-mutant melanoma patients benefit from the combinatorial treatments with BRAF and MEK inhibitors. However, acquired drug resistance strongly limits the efficacy of these targeted therapies in time. Recently, many findings have underscored the involvement of microRNAs as main drivers of drug resistance. In this context, we previously identified a subset of oncomiRs strongly up-regulated in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
